| Product Code: ETC9978469 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Typhoid Vaccine Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Typhoid Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Typhoid Vaccine Market - Industry Life Cycle |
3.4 United States (US) Typhoid Vaccine Market - Porter's Five Forces |
3.5 United States (US) Typhoid Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Typhoid Vaccine Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Typhoid Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing typhoid |
4.2.2 Growing prevalence of typhoid cases in the United States |
4.2.3 Government initiatives promoting vaccination programs |
4.3 Market Restraints |
4.3.1 High cost associated with typhoid vaccines |
4.3.2 Limited accessibility to vaccines in remote areas |
4.3.3 Potential side effects or hesitancy towards vaccines |
5 United States (US) Typhoid Vaccine Market Trends |
6 United States (US) Typhoid Vaccine Market, By Types |
6.1 United States (US) Typhoid Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Typhoid Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Typhoid Vaccine Market Revenues & Volume, By Oral Type Typhoid Vaccine, 2021- 2031F |
6.1.4 United States (US) Typhoid Vaccine Market Revenues & Volume, By Injection Type Typhoid Vaccine, 2021- 2031F |
6.2 United States (US) Typhoid Vaccine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Typhoid Vaccine Market Revenues & Volume, By Hospital, 2021- 2031F |
6.2.3 United States (US) Typhoid Vaccine Market Revenues & Volume, By Research & Academic Laboratories, 2021- 2031F |
6.2.4 United States (US) Typhoid Vaccine Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.2.5 United States (US) Typhoid Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Typhoid Vaccine Market Import-Export Trade Statistics |
7.1 United States (US) Typhoid Vaccine Market Export to Major Countries |
7.2 United States (US) Typhoid Vaccine Market Imports from Major Countries |
8 United States (US) Typhoid Vaccine Market Key Performance Indicators |
8.1 Number of vaccination campaigns conducted in high-risk areas |
8.2 Percentage increase in vaccination coverage among the target population |
8.3 Research and development investment in new typhoid vaccine technologies |
8.4 Number of reported typhoid cases in the United States |
8.5 Compliance rate with recommended vaccination schedules |
9 United States (US) Typhoid Vaccine Market - Opportunity Assessment |
9.1 United States (US) Typhoid Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Typhoid Vaccine Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Typhoid Vaccine Market - Competitive Landscape |
10.1 United States (US) Typhoid Vaccine Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Typhoid Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here